Press releases

Varian Receives FDA 510(k) Clearance for Ethos Therapy

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven...
Read more

Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center

Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at...
Read more

Varian Reports Results for First Quarter of Fiscal Year 2020

First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in...
Read more
See all press releases

Blog posts

InSightive Analytics: Using Data to Transform the Cancer Center at Baton Rouge General

Centerline

With its introduction of the ARIA® oncology information system, Varian made it possible for providers to amass a huge repository o...

Read more

Ethos™ Therapy: Intelligent Adaptation Comes to the Clinic

Centerline

Clinicians have long wanted the ability to adapt radiotherapy treatments to changes in patient anatomy over time. Adaptive treatme...

Read more
Team scripting for Eclipse

Automation: All Part of the Script for Eclipse

Centerline

The ability to automatically generate treatment plans in Eclipse using scripting can have a major impact on how clinicians conduct...

Read more
See all blog posts

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos_image_StillCam_04.png
Ethos_image_StillCam_04.png
See all media assets